• Investment World
• eWorld
• Brand Line
• Mentor
• Life
• Canvas
• Praxis
• Urban Pulse
• Brand Quest
• The New Manager

Stocks

• Quotes
• SE Diary
• Scoreboard
• Open-End Mutual Fund

Cross Currency

• Rates
  
  

Shipping

• Ports
  
  

Archives

• Yesterday
• Datewise
• Resources

Group Sites

• The Hindu
• Business Line
• Sportstar
• Frontline
• The Hindu eBooks
• The Hindu Images

Our Bureau

Mumbai, May 18

The Rs 378-crore Elder Pharmaceuticals Ltd has entered into an in-licensing agreement with Sterisol AB of Sweden to make and market its disinfectant products in India. Sterisol, which manufactures products that control infection and personal hygiene at workplaces and public places, is part of the GePe group.

Earlier this year, Elder had entered into a similar tie-up with Medichem International of UK. Subsequently it launched Trigene, a spray used as a precaution against the bird-flu virus.

The disinfectant and personal hygiene segment is valued at about Rs 850 crore, the Elder statement said.

More Stories on : Alliances & Joint Ventures | Pharmaceuticals

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
Jain Granites bags orders worth Rs 9.65 cr

Copyright © 2006, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line